Gentian
Diagnostic Efficiency
Gentian is a Norwegian IVD company that specialises in developing and manufacturing turbidimetric assays that enable clinical lab professionals to achieve greater operational efficiency, thus providing faster patient results to clinicians. The current portfolio and pipeline of diagnostic reagents span areas of kidney disease, cardiac disease, inflammation, infection and veterinary medicine. Gentian manufactures reagents for both laboratories and industry partners.
By leveraging expertise in Particle-Enhanced Turbidimetric Immunoassays (PETIA) and proprietary nanoparticle technology, Gentian develops immunoassays that enable users to transition from traditional low volume immunology platforms to fully automated clinical chemistry instruments. The typical Gentian customer enjoys shorter turnaround times, streamlined workflows and improved cost efficiency.
GCAL® Plasma and Serum Calprotectin
The Gentian Calprotectin Immunoassay (GCAL®) is the first Particle-Enhanced Turbidimetric Immunoassay (PETIA) for quantitative analysis of total calprotectin in plasma and serum. The assay is rapidly performed in only 10 minutes and can be applied on a wide range of automated clinical chemistry analysers.
Cystatin C
Cystatin C is a superior GFR marker for the diagnosis and therapeutic control of patients of all ages. The Gentian Cystatin C Immunoassay (ERM-DA471/IFCC standardised) is a Particle-Enhanced Turbidimetric Immunoassay (PETIA) for use on a range of clinical chemistry analysers.
Biogenex
Molecular pathology systems
GenomeMe
IHC monoclonal antibodies
RayBiotech
Proteomic discovery tools
BBI Solutions
Diagnostic raw materials
Hillgene
Innovative products for cell and gene therapy